Systemic vasculitides (SV) frequently cause heart damage and cardiovascular events (CVEs). Early diagnosis with non-invasive methods is crucial for managing patients with SV and associated atherosclerosis risk factors.
Area of Science:
Cardiology
Rheumatology
Internal Medicine
Context:
Systemic vasculitides (SV) are a group of rare autoimmune diseases characterized by inflammation of blood vessels.
Cardiac involvement is a significant cause of morbidity and mortality in patients with SV.
Understanding the spectrum of cardiac complications and risk factors is essential for effective patient management.
Purpose:
To investigate the incidence and types of cardiac involvement in patients with SV.
To analyze the patterns of cardiovascular events (CVEs) and identify associated risk factors.
To evaluate the utility of non-invasive diagnostic methods for cardiovascular diseases in SV patients.
Summary:
This study examined 321 patients with various types of SV, including granulomatosis with polyangiitis (GPA), Takayasu's arteritis (TA), polyarteritis nodosa (PAN), and eosinophilic granulomatosis with polyangiitis (EGPA).
Cardiac damage was prevalent, particularly in TA, PAN, and EGPA. CVEs occurred in 15.9% of patients, with higher rates in EGPA and PAN.
Non-invasive methods like echocardiography, myocardial perfusion scintigraphy, and MSCT revealed specific cardiac abnormalities, including aortic regurgitation, left ventricular hypertrophy, diastolic dysfunction, pericarditis, myocardial perfusion disorders, and coronary calcification.
Impact:
Cardiac manifestations in SV are linked to immune inflammation, hypertension, and atherosclerosis.
Patients with both SV and traditional atherosclerosis risk factors are at very high risk for CVEs.
Early detection of cardiac damage using non-invasive techniques can optimize treatment strategies for SV patients.
